- Advertisement -
- Advertisement -

Resscapital’s Key Appointment in Pursuit of Awareness

Report: Systematic Strategies

- Advertisement -

Stockholm (HedgeNordic) – To capitalise on strong performance and continued asset growth in 2022, Resscapital made a key appointment to its investor sales and relations team. The asset manager of Ress Life Investments – a fund that seeks to generate uncorrelated, equity-like returns with low volatility in the secondary market for life settlements – has appointed Hanna Persson as Head of Sales and Investor Relations.

“Today marks a new chapter for me. I’m very excited about joining the fantastic team at Resscapital AB in Stockholm, who offers truly diversifying, stable returns,” Hanna Persson announces on LinkedIn. “Looking forward to reconnect with everyone from my new home,” she adds. “Welcome Hanna! So much looking forward to working together and taking our award-winning fund, Ress Life Investments, to new heights,” comments Jonas Martenson, the founder of Resscapital. 

Persson joins Resscapital from Stockholm-based asset manager East Capital, where she served as Senior Client Relationship Manager. Prior to joining East Capital in September 2021, Persson worked at now-closed systematic investment manager IPM Informed Portfolio Manager in various roles for close to 11 years. Persson’s most recent role at IPM was as Senior Director, Head of Consultant and Investor Relations. 

Hanna Persson will focus on increasing awareness to the attractive investment characteristics of a life insurance portfolio and bring Ress Life Investments to wider investor audience. Ress Life Investments is an alternative investment fund investing in life settlements, which involves buying life insurance policies for one-time payments from policy owners who no longer need or want their policies.  

The fund returned 8.5 percent in 2022, its second-best annual performance since launching in 2011. Under the stewardship of Head of Portfolio Management Anton Pozine, Ress Life Investments has delivered an annualized return of 7.8 percent in U.S. dollars over the past five years. “The performance in 2022 clearly shows the fundamentally uncorrelated return of a life insurance portfolio,” says Gustaf Hagerud, Managing Director at Resscapital. “The asset class offers both a good risk diversification and a counter-cyclical return.” 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

The Value of Short Selling for Symmetry

Stockholm (HedgeNordic) – Stock-picking hedge fund Symmetry Invest has achieved a net-of-fees annualized return of 18 percent since its inception just over 11 years...

Month in Review – June 2024

Stockholm (HedgeNordic) – Despite June marking the end of a long streak of consecutive positive months, the Nordic hedge fund industry still achieved its...

New Equity Managers Join Borea to Bolster Fund Offerings

Stockholm (HedgeNordic) – Following the acquisition of a majority stake by Frendegruppen – a consortium of Norwegian independent banks, Borea Asset Management is strengthening...

Obligo Raises Final €75 Million for PE Fund

Stockholm (HedgeNordic) – Obigo Investment Management has announced the final close of its infrastructure-oriented private equity fund, Obligo Nordic Climate Impact Fund (ONCIF), raising...

RFP: Irish Investor in Search of Tail Risk Mitigation

Stockholm (HedgeNordic) – An Irish institutional investor seeks an overlay manager or managed options strategies to mitigate tail risk in its €2.5 billion fund-of-funds...

Cevian on Buying Spree, Discloses 5% Stake in Smith & Nephew

Stockholm (HedgeNordic) – Swedish activist investor Cevian Capital has disclosed a five percent stake in UK medical device manufacturer Smith & Nephew, signaling intentions...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -